TGF-β also promotes the expansion of regulatory T cells (Tregs) and blocks the cytotoxic function of CD8+ T cells and natural killer (NK) cells, thereby creating an immune-tolerant tumor microenvironment (TME) (34, 35). Here, CD8A is linked to neoplasm.